2m 2m 2m 2m 2m 2m 2m
FOGHORN THERAP (FHTX)
NASDAQ
$7.20+$0.13 (+1.78%)
Price as of Aug 21, 2026 7:58 PM EDT- $419.9MMarket Cap
- 27.16%1-Year Change
- BiotechnologyIndustry
FOGHORN THERAP (FHTX)
$7.20+$0.13 (+1.78%)
FHTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.07 | ||
Change | +$0.06 (+0.86%) | ||
Open | $7.10 | ||
High | $7.35 | ||
Low | $6.95 | ||
Previous Close | $7.01 | ||
Volume | 536,547 | ||
30-Day Average Volume | 277,134 | ||
1-Week Change | 12.94% | ||
1-Month Change | 37.02% | ||
1-Year Change | 27.16% | ||
3-Year Change | -5.86% | ||
5-Year Change | -31.56% | ||
Fundamentals | |||
Shares Outstanding | 59.4M | ||
Total Assets | $203.4M | ||
Market Cap | $419.9M | ||
Enterprise Value | $351.8M | ||
Period: QTR TTM FY | |||
Revenue | $16.1M | ||
Net Income | -$7.2M | ||
Free Cash Flow | -$17.9M | ||
EBIT | -$7.2M | ||
EBITDA | -$7.0M | ||
Net Working Capital | $119.5M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -51 | ||
Enterprise Value/Revenue | 22 | ||
P/B | -5 | ||
P/E | -71 | ||
PEG | -1 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue